Literature DB >> 22581714

Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.

Santosh V Thakkar1, Sangeeta B Joshi, Matthew E Jones, Hasige A Sathish, Steven M Bishop, David B Volkin, C Russell Middaugh.   

Abstract

Since immunoglobulins are conformationally dynamic molecules in solution, we studied the effect of stabilizing and destabilizing excipients on the conformational stability and dynamics of two IgG1 monoclonal antibodies (mAbs; mAb-A and mAb-B) using a variety of biophysical approaches. Even though the two mAbs are of the same IgG1 subtype, the unfolding patterns, aggregation behavior, and pretransition dynamics of these two antibodies were strikingly different in response to external perturbations such as pH, temperature, and presence of excipients. Sucrose and arginine were identified as stabilizers and destabilizers, respectively, on the basis of their influence on conformational stability for both the IgG1 mAbs. The two excipients, however, had distinct effective concentrations and different effects on the conformational stability and pretransition dynamics of the two mAbs as measured by a combination of differential scanning calorimetry, high-resolution ultrasonic spectroscopy, and red-edge excitation shift fluorescence studies. Stabilizing concentrations of sucrose were found to decrease the internal motions of mAb-B, whereas arginine marginally increased its adiabatic compressibility in the pretransition region. Both sucrose and arginine did not influence the pretransition dynamics of mAb-A. The potential reasons for such differences in excipient effects between two IgG1 mAbs are discussed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581714     DOI: 10.1002/jps.23187

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.

Authors:  Lili Wen; Xianxian Zheng; Xinyue Wang; Hairong Lan; Zongning Yin
Journal:  Pharm Res       Date:  2017-04-11       Impact factor: 4.200

2.  Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.

Authors:  Santosh V Thakkar; Neha Sahni; Sangeeta B Joshi; Bruce A Kerwin; Feng He; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2013-08-19       Impact factor: 6.725

3.  Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis.

Authors:  Weiqiang Cheng; Elena Curti; Wanderson C Rezende; Clifford Kwityn; Bin Zhan; Portia Gillespie; Jordan Plieskatt; Sangeeta B Joshi; David B Volkin; Peter J Hotez; C Russell Middaugh; Maria Elena Bottazzi
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

4.  Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.

Authors:  Cavan Kalonia; Ozan S Kumru; Jae Hyun Kim; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-10-09       Impact factor: 3.534

5.  Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.

Authors:  Chaitanya M Sudrik; Theresa Cloutier; Neil Mody; Hasige A Sathish; Bernhardt L Trout
Journal:  Pharm Res       Date:  2019-05-24       Impact factor: 4.200

6.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

7.  Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants.

Authors:  Michaela Blech; Richard Melien; Nuska Tschammer; Beate Presser; Dariush Hinderberger; Patrick Garidel
Journal:  Pharm Res       Date:  2021-12-13       Impact factor: 4.200

8.  Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Toshiaki Tomitsuka; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

9.  Identification of D-Amino Acids in Light Exposed mAb Formulations.

Authors:  Rupesh Bommana; Natalia Subelzu; Olivier Mozziconacci; Alavattam Sreedhara; Christian Schöneich
Journal:  Pharm Res       Date:  2018-10-17       Impact factor: 4.200

10.  Toward Biotherapeutics Formulation Composition Engineering using Site-Identification by Ligand Competitive Saturation (SILCS).

Authors:  Sandeep Somani; Sunhwan Jo; Renuka Thirumangalathu; Danika Rodrigues; Laura M Tanenbaum; Ketan Amin; Alexander D MacKerell; Santosh V Thakkar
Journal:  J Pharm Sci       Date:  2020-11-01       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.